Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ajmaline provocation with ECG imaging for early detection of arrhythmogenic cardiomyopathy
NL-OMON29255Unknown
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ajmaline in arrhythmogenic cardiomyopathy (ACM), sponsored by University Medical Center Utrecht. Primary endpoint: Change in activation time duration in subtricuspid region. Status: unknown.
02
Drugs
ajmaline
03
Conditions
arrhythmogenic cardiomyopathy (ACM)
Beyond the preview
Go deeper on NL-OMON29255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29255.